Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Diastereomeric Salt Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113429328A details a low-cost tartaric acid resolution method for chiral fluorinated pyrrolidines, enabling scalable API intermediate production.
Advanced resolution process for IRS drug intermediates via diastereomeric salt crystallization. Enhances purity and reduces manufacturing costs for pharmaceutical supply chains.
Solve low-yield and low-purity issues in trans-2-aminocyclohexanol production. This patent's 2-methoxyphenylacetic acid resolution method achieves >99%ee and 67% yield, reducing costs for pharma intermediates.